ARBITES Tablet 40/5 mg

Adult dose

The recommended dosage of this medication is 1 tablet once daily, to be taken with water regardless of meals. It is advisable to take it at the same time each day (e.g., morning). - 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg of amlodipine or 40 mg of telmisartan. - 80/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg of amlodipine or this medication 40/5 mg.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, and its use is not recommended.

This medication can pose a serious risk to the fetus, especially during the second and third trimesters of pregnancy, and should not be used during pregnancy. If pregnancy is planned or confirmed, the use of this medication should be immediately discontinued, and other safe treatments should be sought. This medication should not be used in patients with certain conditions, such as severe liver disease, obstructive biliary disease, left ventricular outflow obstruction, severe hypotension, or cardiac shock. Additionally, in diabetic patients with severely reduced kidney function, the combination of this medication with certain drugs should be avoided. Special precautions are required for patients with primary aldosteronism or aortic stenosis, hypertrophic cardiomyopathy. Caution should also be exercised when administering to patients with impaired liver function, with dosage adjustments necessary. Patients with gastrointestinal conditions should be aware of the risk of gastrointestinal bleeding when taking this medication. Patients with renal vascular disease may experience increased risk of hypotension or renal failure when taking this medication, and regular blood tests and monitoring are necessary. Elderly patients may be more sensitive to this medication; therefore, it is advisable to start with a lower initial dose and gradually increase it. The risk of side effects such as hypotension, renal failure, and hyperkalemia may increase when this medication is combined with other antihypertensives, so caution is required during combined therapy. Overdosage can result in symptoms such as hypotension, dizziness, and irregular heart rate, and immediate medical attention should be sought. During the use of this medication, drowsiness or dizziness may occur, so caution is recommended when driving or operating hazardous machinery. Nursing mothers are advised not to take this medication and should consult a healthcare professional if necessary. The safety and efficacy of this medication have not been sufficiently established in children and adolescents, hence its use is not recommended. This medication should be kept out of reach of children and should not be transferred to other containers. Adherence to the prescribed dosages and consultation with a healthcare professional if adverse reactions occur is essential.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, breathlessness, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, difficulty in breathing or shortness of breath, asthma attacks, respiratory issues accompanied by coughing and fever, jaundice (yellowing of the skin or eyes), extreme fatigue, sudden and severe headache, lightning headache, seizures, confusion of consciousness, visual disturbances, paralysis,

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia
• depression

This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it is advisable to store the medication at room temperature, between 1 to 30 degrees Celsius.

Appearance

White to light yellow and pale blue, bi-convex oval double tablet

Package unit

30 tablets (10 tablets/PTP*3)